Merck Wants FCA Claim Tossed After Millennium Escapes Suit
By Daniel Wilson (April 3, 2015, 7:19 PM EDT) -- Merck and Co. Inc. on Friday asked a California federal judge to dismiss a whistleblower's False Claims Act allegations regarding off-label promotion of Integrilin and kickbacks, saying the judge's grounds for dismissing similar claims against Millennium Pharmaceuticals Inc. were equally applicable to it.
The same FCA public disclosure bar that U.S. District Judge Morrison C. England Jr. had found required him to toss off-label marketing claims brought by relator Frank Solis against Millennium over its marketing of the blood thinner should similarly apply to effectively identical claims against Merck and its predecessor Schering-Plough Corp., the company argued.
"The analysis set forth...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!